Acylaminothiazolderivater og anvendelse deraf som beta-amyloid-hæmmere

Compounds of formula (I) as defined herein: inhibit the formation of the -amyloid peptide ( -A4) and are, therefore, useful in the treatment of pathologies in which a -amyloid peptide ( -A4) formation inhibitor provides a therapeutic benefit. Particular such pathologies are senile dementia, Alzheime...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BALTZER, SYLVIE, PASCAL, MARC, VAN DORSSELAER, VIVIANE
Format: Patent
Sprache:dan
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BALTZER, SYLVIE
PASCAL, MARC
VAN DORSSELAER, VIVIANE
description Compounds of formula (I) as defined herein: inhibit the formation of the -amyloid peptide ( -A4) and are, therefore, useful in the treatment of pathologies in which a -amyloid peptide ( -A4) formation inhibitor provides a therapeutic benefit. Particular such pathologies are senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy, cerebrovascular disorders, frontotemporal dementias and Pick's disease, post-traumatic dementias, pathologies linked to neuroinflammatory processes, Huntington's disease and Korsakov's syndrome.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DK1709018TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DK1709018TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DK1709018TT33</originalsourceid><addsrcrecordid>eNrjZHB3TK7MSczNzMsvychMrMrPSUktyixLLEktUshPV0jMK0vNS0nNKU5VAIonpikU5-cqJKWWJOom5lbm5Gem6GYcXpabm1qUysPAmpYIVMcLpbkZFN1cQ5w9dFML8uNTiwsSk1PzUkviXbwNzQ0sDQwtQkKMjYlRAwAUYjWo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Acylaminothiazolderivater og anvendelse deraf som beta-amyloid-hæmmere</title><source>esp@cenet</source><creator>BALTZER, SYLVIE ; PASCAL, MARC ; VAN DORSSELAER, VIVIANE</creator><creatorcontrib>BALTZER, SYLVIE ; PASCAL, MARC ; VAN DORSSELAER, VIVIANE</creatorcontrib><description>Compounds of formula (I) as defined herein: inhibit the formation of the -amyloid peptide ( -A4) and are, therefore, useful in the treatment of pathologies in which a -amyloid peptide ( -A4) formation inhibitor provides a therapeutic benefit. Particular such pathologies are senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy, cerebrovascular disorders, frontotemporal dementias and Pick's disease, post-traumatic dementias, pathologies linked to neuroinflammatory processes, Huntington's disease and Korsakov's syndrome.</description><language>dan</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20111114&amp;DB=EPODOC&amp;CC=DK&amp;NR=1709018T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20111114&amp;DB=EPODOC&amp;CC=DK&amp;NR=1709018T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BALTZER, SYLVIE</creatorcontrib><creatorcontrib>PASCAL, MARC</creatorcontrib><creatorcontrib>VAN DORSSELAER, VIVIANE</creatorcontrib><title>Acylaminothiazolderivater og anvendelse deraf som beta-amyloid-hæmmere</title><description>Compounds of formula (I) as defined herein: inhibit the formation of the -amyloid peptide ( -A4) and are, therefore, useful in the treatment of pathologies in which a -amyloid peptide ( -A4) formation inhibitor provides a therapeutic benefit. Particular such pathologies are senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy, cerebrovascular disorders, frontotemporal dementias and Pick's disease, post-traumatic dementias, pathologies linked to neuroinflammatory processes, Huntington's disease and Korsakov's syndrome.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHB3TK7MSczNzMsvychMrMrPSUktyixLLEktUshPV0jMK0vNS0nNKU5VAIonpikU5-cqJKWWJOom5lbm5Gem6GYcXpabm1qUysPAmpYIVMcLpbkZFN1cQ5w9dFML8uNTiwsSk1PzUkviXbwNzQ0sDQwtQkKMjYlRAwAUYjWo</recordid><startdate>20111114</startdate><enddate>20111114</enddate><creator>BALTZER, SYLVIE</creator><creator>PASCAL, MARC</creator><creator>VAN DORSSELAER, VIVIANE</creator><scope>EVB</scope></search><sort><creationdate>20111114</creationdate><title>Acylaminothiazolderivater og anvendelse deraf som beta-amyloid-hæmmere</title><author>BALTZER, SYLVIE ; PASCAL, MARC ; VAN DORSSELAER, VIVIANE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DK1709018TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>dan</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BALTZER, SYLVIE</creatorcontrib><creatorcontrib>PASCAL, MARC</creatorcontrib><creatorcontrib>VAN DORSSELAER, VIVIANE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BALTZER, SYLVIE</au><au>PASCAL, MARC</au><au>VAN DORSSELAER, VIVIANE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Acylaminothiazolderivater og anvendelse deraf som beta-amyloid-hæmmere</title><date>2011-11-14</date><risdate>2011</risdate><abstract>Compounds of formula (I) as defined herein: inhibit the formation of the -amyloid peptide ( -A4) and are, therefore, useful in the treatment of pathologies in which a -amyloid peptide ( -A4) formation inhibitor provides a therapeutic benefit. Particular such pathologies are senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy, cerebrovascular disorders, frontotemporal dementias and Pick's disease, post-traumatic dementias, pathologies linked to neuroinflammatory processes, Huntington's disease and Korsakov's syndrome.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language dan
recordid cdi_epo_espacenet_DK1709018TT3
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Acylaminothiazolderivater og anvendelse deraf som beta-amyloid-hæmmere
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T22%3A02%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BALTZER,%20SYLVIE&rft.date=2011-11-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDK1709018TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true